Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma

Acta Oto-Laryngologica

Volumn 125, Issue 7, 2005, Pages 779-785

  Bandoh, Nobuyuki ^a   Hayashi, Tatsuya ^a   Takahara, Miki ^a   Kishibe, Kan ^a   Ogino, Takeshi ^a   Katayama, Akihiro ^a   Imada, Masanobu ^a   Nonaka, Satoshi ^a   Harabuchi, Yasuaki ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Apoptosis; Cell proliferation; Maxillary sinus squamous cell carcinoma; p21; p27; p53; Prognosis

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUS CARCINOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; COHORT STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MAXILLARY SINUS NEOPLASMS; MIDDLE AGED; MUTATION; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 22944465392     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480410023056     Document Type: Article

References (25)

1. Bandoh N, Hayashi T, Kishibe K, Takahara M, Imada M, Nonaka S, et al. Prognostic value of p53 mutations, bax and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer 2002;94:1968-80.
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
3. Hunter T. Braking the cycle. Cell 1993;75:839-41.
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
5. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995;267: 1024-7.
6. Fang F, Orend G, Watanabe N, Hunter T, Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage Science 1996;271:499-502.
7. Ohashi K, Nemoto T, Eishi Y, Matsuno A, Nakamura K, Hirokawa K. Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas. Virchows Arch 1997;430:389-95.
8. Hirvikoski P, Kellokoski JK, Kumpulainen EJ, Virtaniemi JA, Johansson RT, Kosma VM. Downregulation of p21/ WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma. J Clin Pathol 1999;52:440-4.
9. Van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation p53 status and cyclin D1 expression. J Oral Pathol Med 1998;27:367-75.
10. Erber R, Klein W, Andl T, Enders C, Born AI, Conradt C, et al. Aberrant p21 (CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 1997;74:383-9.
11. Fujieda S, Inuzuka M, Tanaka N, Sunaga H, Fan GK, Ito T, et al. Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int J Cancer 1999;84:315-20.
12. Fan GK, Fujieda S, Sunaga H, Tsuzuki H, Ito N, Saito H. Expression of protein p27 is associated with progression and prognosis in laryngeal cancer. Laryngoscope 1999;109:815-20.
13. Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, et al. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Clin Cancer Res 1999;5:801-6.
14. Izawa H, Yonemitsu N, Shin T, Sugihara H. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Auris Nasus Larynx 1999;26:317-30.
15. Natsugoe S, Nakashima S, Matsumoto M, Xiangming C, Okumura H, Kijima F, et al. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. Clin Cancer Res 1999;5:2445-9.
16. Yuen PW, Chow V, Choy J, Lam KY, Ho WK, Wei WI. The clinicopathologic significance of p53 and p21 expression in the surgical management of lingual squamous cell carcinoma. Am J Clin Pathol 2001;116:240-5.
17. Mineta H, Borg A, Dictor M, Wahlberg P, Akervall J, Wennerberg J. p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma. Br J Cancer 1998;78:1084-90.
18. Chomchai JS, Du W, Sarkar FH, Li YW, Jacobs JR, Ensley JF, et al. Prognostic significance of p53 gene mutations in laryngeal cancer. Laryngoscope 1999;109:455-9.
19. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993;8:203-7.
20. Nadal A, Jares P, Cazorla M, Fernandez PL, Sanjuan X, Hernandez L, et al. p21WAF1/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol 1997; 183:156-63.
21. Katayose Y, Kim M, Rakkar AN, Li Z, Cowan KH, Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 1997;57: 5441-5.
22. Han EK, Begemann M, Sgambato A, Soh JW, Doki Y, Xing WQ, et al. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis Cell Growth Differ 1996; 7:699-710.
23. Lera J, Lara PC, Perez S, Cabrera JL, Santana C. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy. Cancer 1998;83:2493-501.
24. Homma A, Furuta Y, Oridate N, Nakano Y, Yagi K, Nagahashi T, et al. Correlation of clinicopathological parameters and biological markers related to apoptosis and proliferative activity with clinical outcome in squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy. Auris Nasus Larynx 2001;28:S87-94.
25. Willett CG, Warland G, Hagan MP, Daly WJ, Coen J, Shellito PC, et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13: 1417-24.